1. Home
  2. PTGX vs GSAT Comparison

PTGX vs GSAT Comparison

Compare PTGX & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • GSAT
  • Stock Information
  • Founded
  • PTGX 2006
  • GSAT 2003
  • Country
  • PTGX United States
  • GSAT United States
  • Employees
  • PTGX N/A
  • GSAT N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • GSAT Telecommunications Equipment
  • Sector
  • PTGX Health Care
  • GSAT Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • GSAT Nasdaq
  • Market Cap
  • PTGX 3.7B
  • GSAT 3.9B
  • IPO Year
  • PTGX 2016
  • GSAT 2006
  • Fundamental
  • Price
  • PTGX $61.69
  • GSAT $34.48
  • Analyst Decision
  • PTGX Strong Buy
  • GSAT Strong Buy
  • Analyst Count
  • PTGX 9
  • GSAT 3
  • Target Price
  • PTGX $70.44
  • GSAT $43.33
  • AVG Volume (30 Days)
  • PTGX 925.0K
  • GSAT 1.3M
  • Earning Date
  • PTGX 11-06-2025
  • GSAT 11-06-2025
  • Dividend Yield
  • PTGX N/A
  • GSAT N/A
  • EPS Growth
  • PTGX N/A
  • GSAT N/A
  • EPS
  • PTGX 0.80
  • GSAT N/A
  • Revenue
  • PTGX $209,180,000.00
  • GSAT $260,664,000.00
  • Revenue This Year
  • PTGX N/A
  • GSAT $7.93
  • Revenue Next Year
  • PTGX $248.17
  • GSAT $11.32
  • P/E Ratio
  • PTGX $73.55
  • GSAT N/A
  • Revenue Growth
  • PTGX N/A
  • GSAT 14.85
  • 52 Week Low
  • PTGX $33.31
  • GSAT $15.00
  • 52 Week High
  • PTGX $61.89
  • GSAT $41.10
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.67
  • GSAT 63.38
  • Support Level
  • PTGX $57.90
  • GSAT $29.36
  • Resistance Level
  • PTGX $60.40
  • GSAT $40.56
  • Average True Range (ATR)
  • PTGX 2.47
  • GSAT 2.34
  • MACD
  • PTGX 0.06
  • GSAT 0.13
  • Stochastic Oscillator
  • PTGX 94.34
  • GSAT 51.73

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: